Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Pelletier

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
Biochemical Society Transactions|January 20, 2023
Therapeutic targeting of eukaryotic initiation factor (eIF) 4EJerry Pelletier, Nahum Sonenberg
Translation (Austin, Tex.)|June 24, 2016
Hippuristanol - A potent steroid inhibitor of eukaryotic initiation factor 4ARegina Cencic, Jerry Pelletier
Future Medicinal Chemistry|March 24, 2011
Inhibitors of translation initiation as cancer therapeuticsLisa Lindqvist, Jerry Pelletier
Cold Spring Harbor Perspectives in Biology|February 15, 2018
Therapeutic Opportunities in Eukaryotic TranslationJennifer Chu, Jerry Pelletier
Biochimica Et Biophysica Acta|February 7, 2013
Throwing a monkey wrench in the motor: targeting DExH/D box proteins with small molecule inhibitorsRegina Cencic, Jerry Pelletier
Anticancer Research|July 31, 2012
Tumor progression and metastasis: role of translational deregulationZeina Nasr, Jerry Pelletier
International Journal of Molecular Sciences|June 25, 2020
General and Target-Specific DExD/H RNA Helicases in Eukaryotic Translation InitiationLeo Shen, Jerry Pelletier
Physiological Genomics|February 18, 2004
Insights into the physiological role of WT1 from studies of genetically modified miceMaria Teresa Discenza, Jerry Pelletier
Oncotarget|March 8, 2011
Targeting translation dependence in cancerAbba Malina, Regina Cencic, Jerry Pelletier
The EMBO Journal|April 21, 2007
Translation of nonSTOP mRNA is repressed post-initiation in mammalian cellsNobuyoshi Akimitsu, Junichi Tanaka, Jerry Pelletier
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
Biochemical Society Transactions|January 20, 2023
Therapeutic targeting of eukaryotic initiation factor (eIF) 4EJerry Pelletier, Nahum Sonenberg
Translation (Austin, Tex.)|June 24, 2016
Hippuristanol - A potent steroid inhibitor of eukaryotic initiation factor 4ARegina Cencic, Jerry Pelletier
Future Medicinal Chemistry|March 24, 2011
Inhibitors of translation initiation as cancer therapeuticsLisa Lindqvist, Jerry Pelletier
Cold Spring Harbor Perspectives in Biology|February 15, 2018
Therapeutic Opportunities in Eukaryotic TranslationJennifer Chu, Jerry Pelletier
Biochimica Et Biophysica Acta|February 7, 2013
Throwing a monkey wrench in the motor: targeting DExH/D box proteins with small molecule inhibitorsRegina Cencic, Jerry Pelletier
Anticancer Research|July 31, 2012
Tumor progression and metastasis: role of translational deregulationZeina Nasr, Jerry Pelletier
International Journal of Molecular Sciences|June 25, 2020
General and Target-Specific DExD/H RNA Helicases in Eukaryotic Translation InitiationLeo Shen, Jerry Pelletier
Physiological Genomics|February 18, 2004
Insights into the physiological role of WT1 from studies of genetically modified miceMaria Teresa Discenza, Jerry Pelletier
Oncotarget|March 8, 2011
Targeting translation dependence in cancerAbba Malina, Regina Cencic, Jerry Pelletier
The EMBO Journal|April 21, 2007
Translation of nonSTOP mRNA is repressed post-initiation in mammalian cellsNobuyoshi Akimitsu, Junichi Tanaka, Jerry Pelletier
Pageof 24